Have a personal or library account? Click to login

Systemic Redox Status of Rats Treated with Different Doses of Perfluorocarbon Based Blood Substitute- Perftoran®

Open Access
|Sep 2022

References

  1. 1. Jägers J, Wrobeln A, Ferenz KB. Perfluorocarbon-based oxygen carriers: from physics to physiology. Pflugers Arch. 2021;473(2):139-50.10.1007/s00424-020-02482-2760737033141239
  2. 2. Bucala R, Kawakami M, Cerami A. Cytotoxicity of a perfluorocarbon blood substitute to macrophages in vitro. Science. 1983;220:965–97.10.1126/science.68449226844922
  3. 3. Castro CI, Briceno JC. Perfluorocarbon-based oxygen carriers: review of products and trials. Artif Organs. 2010;34:622–34.
  4. 4. Gollan F, Clark L. Organ perfusion with fluorocarbon fluid. Physiologist. 1966;9:H292
  5. 5. Sloviter HA, Kamimoto T. Erythrocyte substitute for perfusion of brain. Nature. 1967;216:458–6010.1038/216458a06057248
  6. 6. Honda K, Hoshino S, Shoji M, Usuba A, Motoki R, Tsuboi M, et al. Clinical use of a blood substitute. N Engl J Med. 1980;303(7):391-2.10.1056/NEJM1980081430307107393252
  7. 7. Vorobyev SI, Ivanitsky GR. Perfluorocarbon emulsion Perftoran - the plasma substite with gastransporting function. // VI Inter. Sympos. on Blood Substit. 1996; Canada. Montreal.
  8. 8. Vorobyev SI, Ivanitsky GR. Perfluorocarbon emulsion, stabilised proxanol. Preprint. Pushchino. 1994.
  9. 9. Winslow RM. Current status of blood substitute research: towards a new paradigm. J Intern Med. 2003;253(5):508-17.10.1046/j.1365-2796.2003.01150.x12702028
  10. 10. Kerins DM. Role of the perfluorocarbon Fluosol-DA in coronary angioplasty. Am J Med Sci. 1994;307(3):218-21.10.1097/00000441-199403000-000098160713
  11. 11. Rajendran P, Nandakumar N, Rengarajan T, Palaniswami R, Gnanadhas NE, Lakshminarasaiahet U, et al. Antioxidants and human diseases. Clin Chim Acta. 2014;436:332-47.10.1016/j.cca.2014.06.00424933428
  12. 12. Brand MD. The sites and topology of mitochondrial superoxide production. Exp Gerontol. 2010;45:466-72.10.1016/j.exger.2010.01.003287944320064600
  13. 13. Fujii H, Nakai K, Fukagawa M. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. Ther Apher Dial. 2011;15(2):125-28.10.1111/j.1744-9987.2010.00883.x21426501
  14. 14. Ferrari RS, Thomaz LDGR, Simoneti LEL, Ulbrich JM, Andrade CF. Effect of vaporized perfluorocarbon on oxidative stress during the cold ischemia phase of lung graft preservation. J Bras Pneumol. 2019;45(4):e20170288.10.1590/1806-3713/e20170288673372330942284
  15. 15. Khalighi Z, Rahmani A, Cheraghi J, Ahmadi MR, Soleimannejad K, Asadollahi R, Asadollahi K. Perfluorocarbon attenuates inflammatory cytokines, oxidative stress and histopathologic changes in paraquat-induced acute lung injury in rats. Environ Toxicol Pharmacol. 2016;42:9-15.10.1016/j.etap.2015.12.00226766533
  16. 16. Auclair C, Voisin E. Nitroblue tetrazolium reduction. In: Greenvvald RA, editor. Handbook of methods for oxygen radical research. CRC Press, Boca Raton; 1985, p. 123–32.
  17. 17. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Meth. 1980;38:161–70.10.1016/0022-1759(80)90340-36778929
  18. 18. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15 N] nitrate in biological fluids. Anal Biochem. 1982;126:131–810.1016/0003-2697(82)90118-X7181105
  19. 19. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–8.10.1016/0003-2697(79)90738-336810
  20. 20. McCord JM, Fridovich I. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem. 1969;244:6056–63.
  21. 21. Beutler E. Catalase, red cell metabolism. In: Beutler E, editor. Manual of biochemical methods. Grune and Stratton, New York; 1982; p. 105.
  22. 22. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882-8.
  23. 23. Jakovljevic V, Vorobyev S, Bolevich S, Morozova E, Bolevich S, Saltykov A, et al. Dose-dependent effects of perfluorocarbon-based blood substitute on cardiac function in myocardial ischemia-reperfusion injury. Mol Cell Biochem. 2022;10.1007/s11010-022-04479-0. doi: 10.1007/s11010-022-04479-035643877
  24. 24. Chiste RC, Freitas M, Mercadante AZ, Fernandes E. Superoxide Anion Radical: Generation and Detection in Cellular and Non-Cellular Systems. Curr Med Chem. 2015;22(37):4234-56.10.2174/092986732266615102910431126511471
  25. 25. Bekyarova G, Yankova T, Galunska B. Increased antioxidant capacity, suppression of free radical damage and erythrocyte aggrerability after combined application of alpha-tocopherol and FC-43 perfluorocarbon emulsion in early postburn period in rats. Artif Cells Blood Substit Immobil Biotechnol. 1996;24(6):629-41.10.3109/107311996091188888922232
  26. 26. Zhang Z, Liang Z, Li H, et al. Perfluorocarbon reduces cell damage from blast injury by inhibiting signal paths of NF-κB, MAPK and Bcl-2/Bax signaling pathway in A549 cells. PLoS One. 2017;12(3):e0173884.10.1371/journal.pone.0173884536030928323898
  27. 27. Maas DA, Vallès A, Martens GJM. Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia. Transl Psychiatry. 2017;7(7):e1171.10.1038/tp.2017.138553811828934193
  28. 28. Zhu Z, Li X, Chen W, Zhao Y, Li H, Qing C, et al. Prenatal stress causes gender-dependent neuronal loss and oxidative stress in rat hippocampus. J Neurosci Res. 2004;78(6):837-44.10.1002/jnr.2033815499594
  29. 29. Altuntas I, Aksoy H, Coskun I, Caykoylu A, Akcay F. Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clin Chem Lab Med. 2000;38:1277–81.10.1515/CCLM.2000.20111205693
  30. 30. Spiess BD. Perfluorocarbon Emulsions, Platelet Counts, and Inflammation. Shock. 2019;52(1):13-8.10.1097/SHK.000000000000115429642229
  31. 31. Lehmler HJ. Anti-inflammatory effects of perfluorocarbon compounds. Expert Rev Respir Med. 2008;2(2):273-89.10.1586/17476348.2.2.27320477255
  32. 32. Dani C, Costantino ML, Martelli E, Corno C, Fiore GB, Buonocore G, et al. Perfluorocarbons attenuate oxidative lung damage. Pediatr Pulmonol. 2003;36(4):322-9.10.1002/ppul.1036812950046
DOI: https://doi.org/10.2478/sjecr-2022-0034 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 209 - 216
Submitted on: Aug 13, 2022
Accepted on: Aug 25, 2022
Published on: Sep 20, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2022 Morozova Elena, Vorobyev Sergey, Bolevich Sergey, Bolevich Stefani, Saltykov Alexander, Orlova Alexandra, Sinelnikova Tatiana, Kruglova Maria, Morgan Bella, Mikhaleva Anastasia, Khitrov Alexander, Vladimir Jakovljevic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.